Have an account? Log in.
I don't have an account.
BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and lowers the price target from $1.5 to $1.
Xtant Medical Hldgs (AMEX:XTNT) sees FY2026 sales of $95.000 million-$99.000 million vs $110.100 million analyst estimate.
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly sales of $32.357 million which beat the analyst consensus estimate of $30.750 million by 5.23 percent. This is a 2.68 percent increase over sales of $31.513 million the
The Starter plan only unlocks analyses for the 25 stocks tracked over the past month. With the Compact plan, you get access to all stocks from Germany and the USA – with Premium, worldwide access.